Recent Advances in Nanomaterials for Therapy and Diagnosis of Cardiovascular Disease

Cardiovascular diseases (CVDs) are among the world’s widely affected disorders, including ischemia and stroke. Acute Myocardial (AMI) is a deadly disease caused by irreversible damage to left ventricular heart tissues. The thromboembolic plaque stops oxygen supply main blood vessels ventricles. During chronic inflammation, myocardial infarction free radicals stable myocardium, smooth muscles cell, epithelial cells outer membrane loss wall smoothing dilation. Specially constructed scaffolds made of biological nanoparticles have been created shield ventricle from further injury recover ischemic endothelial cells. Preclinical experiments demonstrated that containing growth factors will regenerate tissue into pericardium in good working order. Various medicinal approaches treat cardiovascular conditions at different stages discussed this review article, with biomaterials receiving special attention. This addresses manipulation manufacturing biomedical implantable devices using nanomedicine methods drug delivery principles. use graphene exosomal nanovesicle therapeutics recently progressed research studies.